Severe community-acquired pneumonia: clinical manifestations in obese patients
Închide
Articolul precedent
Articolul urmator
412 2
Ultima descărcare din IBN:
2023-11-05 06:38
SM ISO690:2012
FETCO-MEREUŢĂ, Diana, CAȘCAVAL, Virginia. Severe community-acquired pneumonia: clinical manifestations in obese patients. In: MedEspera: International Medical Congress for Students and Young Doctors, Ed. 8th edition, 24-26 septembrie 2020, Chişinău. Chisinau, Republic of Moldova: 2020, 8, pp. 166-167. ISBN 978-9975-151-11-5.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
MedEspera
8, 2020
Congresul "International Medical Congress for Students and Young Doctors"
8th edition, Chişinău, Moldova, 24-26 septembrie 2020

Severe community-acquired pneumonia: clinical manifestations in obese patients


Pag. 166-167

Fetco-Mereuţă Diana, Cașcaval Virginia
 
”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
 
Disponibil în IBN: 23 decembrie 2020


Rezumat

Introduction. Community-acquired pneumonia is a leading cause of morbidity and mortality worldwide, and is strongly influenced by comorbid conditions. Obesity is associated with higher mortality rate directly proportional to higher body mass index. Obesity is also associated with an increased risk of acquiring infections such as community-acquired pneumonia. Aim of the study. To evaluate the obesity influence on clinical manifestations in patients with severe community-acquired pneumonia. Materials and methods. The retrospective case-control study was based on case histories analysis of patients hospitalized with severe community-acquired pneumonia in the Department of Internal Medicine, Sfânta Treime Municipal Hospital between years 2018 and 2019. The study were included 82 patients aged between 34 and 83 years, divided in two groups: group 1 (41 patients with obesity) and group 2 (41 normal weight patients). Results. Inavasive ventilation was necessary in 34% (28/82 patients), 16 patients with obesity and 12 normal weight patients (19% vs 15%) (p>0.05). The mean duration of inavasive ventilation was 5.7±2.5 days in obese vs 5.5±3.7 days in normal weight patients. Among 82 patients, the main duration of hospitalization was 14.5±5.2 days. The obese patients lengths of hospital stay was 15±3.2 days vs 13±2.4 days in normal weight patients (p<0.05). Duration of antibacterial therapy was 19.3±7.3 days in obese and 18.2±5.8 days in normal weight patients (p<0.05). The group of obese patients consisted of obesity class 1- 24.4% (10/41 patients), class 2 - 26.8% (11/41 patients) and class 3 - 48.7% (20/41 patients). The presence of complications in obese was reported in all the cases, of them - 100% of acute respiratory failure, 14.6% of ARDS, 39% of pleural effusion, 22% of cardiogenic pulmonary edema, 7% of sepsis and 12% of multiple organ dysfunction syndrome. Conclusions. The study revealed that obesity was positively associated with a longer hospitalization stay and longer duration of antibacterial therapy. No association was found between obesity and more frequent need for mechanical ventilation. The most severe complications were registered in patients with class 3 obesity.

Cuvinte-cheie
community-acquired pneumonia, obesity, complications